Augmented Reality Visor to Dramatically Improve Surgery

Employing new photonics technology, European scientists are developing a new Augmented Reality surgical visor in a bid to improve accuracy of interventions, showing anaesthetic and medical data while superimposing a patient's x-ray in perfect unison with their body, meaning surgeons never having to look away during an operation and surgery times reduced by over 20 minutes for every 3 hours.

The VOSTARS ('Video Optical See-Through Augmented Reality surgical System') medical visor is a head-mounted display (HMD) system that is capable of superimposing the patient's x-ray images in perfect 3D unison with their anatomy.

The visor also presents a patient’s anaesthetic data, heart rate, body temperature, blood pressure, and breathing rates, conveniently into the surgeon’s field of vision, in a drive to increase accuracy by focusing on the operation and reduce time by never having to look away.

The project forecasts a significant improvement of the intervention accuracy coupled with a reduction in times spent in an operation and under anaesthetic by at least 11 %.

Although Augmented Reality for surgical procedures has been talked about in academic and industrial research since the 1990s, a tool joining a surgeon's natural perception with patient data has not yet been widely implemented.

However it has been the use of photonics components, with the small, high-luminous micro display, the LED optical waveguide, and the array of microns to project a 2D x-ray image in front of the user that has been fundamental to realising this one time science fiction.

Project coordinator Dr Vincenzo Ferrari, biomedical engineering researcher at the Department of Information Engineering, at the University of Pisa, explains: "With this state-of-the-art, highly ergonomic visor, we intend to provide all the information required to improve surgery. The primary goal is to reduce not just surgery times, but also the time spent under anaesthetic and the cost involved in any operation."

"For the patient, this means saving off 20 minutes of every 3 hours of surgery and the guarantee of an extremely accurate intervention," said Dr Ferrari.

In the same way that a facing camera on a smartphone films moving images, the VOSTARS system works by capturing what the surgeon sees from a head-mounted camera. The system then 'merges' this footage of reality with the patient’s medical images, from CT, MRI, or 3DUS scans.

The central processor, using the most advanced registration techniques available for surgical navigation, then presents a real-time hybrid image on the visor 'dashboard' to the surgeon.

"Imagine driving with a sat-nav: we know how to drive and roughly where to go, but with real-time information, like speed, distance and time presented to us, we can take the most efficient route in the quickest time and perhaps more safely."

"However, rather than having that information on a small GPS screen, our important patient data, like the surgical target in the anatomy, anaesthetic info, breathing and heart rates for example, are all integrated instantly into the surgical visor.

"A clinician can move freely while still seeing the patient, the hybrid x-ray image and all of critical data all at once in a surgical 'dashboard' inside the screen. The surgeon, the patient and the procedure are all at one."

Hybrid
Scientists at VOSTARS are building a hybrid of the two existing AR headsets approaches that combines all the benefits of both a video see-through (VST) system and optical see-through (OST) head-mounted display.

Fabrizio Cutolo, engineer and expert in wearable augmented reality systems, believes neither VST nor OST alone was suitable for operating on a live patient: "When operating on a real person, it was clear to us that the benefits of OST and VST systems could be combined to make a hybrid device."

In 'optical see-through' (OST) systems, as in Microsoft Hololens, the user has a direct view of the natural environment with the computer-generated images superimposed on a user's field of vision using a semi-transparent mirror. This gives the user a more naturalistic experience, superimposing small amounts of the virtual onto the real world.

With 'video see-through' (VST) systems (as seen in the Occulus Rift headsets), the user is submerged in the virtual world, seeing through a closed head-mounted display (HMD) together with stereo cameras, experiencing life through screens. Since VST systems capture the video-image as seen by the user in real time it is good for aligning the real and virtual worlds.

"For something as critical as an operation, we had to have the naturalistic 'feel' of OST, while having the fluid interaction of the VST. Therefore a brand new device had to be made from scratch, rather than extend an existing technology. The VST-OST Augmented Reality hybrid was born."

Already 3 months into the 3 year project, VOSTARS aims to have a working prototype of the hybrid device ready for May of 2018. Initially being trialled on a number of procedures to the head, including Maxillofacial (jaws and face) surgery, neuro surgery, ENT (ear, nose and throat) and orthopedic surgery, the project hopes to be available to end users in 3 years, with mass production by 2022.

Coordinated in Italy at Department of Information Engineering and the EndoCAS Center for Computer Assisted Surgery (Pisa University), the VOSTARS project received a grant of €3,816,440 from Horizon 2020 via the Photonics Public Private Partnership.

Participants from four European countries include: (Germany) SCOPIS GMBH, Charité - Universitätsmedizin Berlin, Sankt Gertrauden Krankenhaus GMBH, Technische Universitaet Muenchen, Pilotfish GMBH; (Italy) Alma Mater Studiorum-Universita Di Bologna, Scuola Superiore Di Studi Universitare E Di Perfezionamento Sant'Anna; (United Kingdom) VREO Innovation; (France) Optinvent, Commissariat A L'Energie Atomique et aux Energies Alternatives.

For further information, please visit:
http://www.vostars.eu

About Photonics21
Photonics21 is the European Technology Platform (ETP) for photonics, a technology encompassing all of the products and processes around the emission, manipulation and detection of light. Photonics is integral to a wide range of industries that include the medical, healthcare, transport, manufacturing, and telecommunications sectors.

"Photonics21" was set up in December 2005 to bring the community of photonics researchers and industries together. The European Commission defined photonics as one of five European Key Enabling Technologies (KET's) in September 2009. Shortly after, the European Research & Innovation Program "Horizon 2020" invited Photonics21 to become a "Public Private Partnership" (PPP). The "Photonics 21 Association", a legal entity under Belgium law, became the private contract partner in November 2013 in a Public Private Partnership (PPP) in conjunction with the EU Commission.

Today Photonics21 represents more than 3000 personal members from across Europe and abroad. Our members are experts in the photonics industry, research organisations and universities who actively engage with us to develop a joint photonics strategy for future research and innovation in Europe.

With the global photonics market growing from €350 Billion in 2011 to €447 Billion in 2015, Photonics remains a strong industry. The European photonics industry, estimated to be worth €70 billion, has considerable global leadership positions and employs over 300,000 people directly.

With positive growth forecast, current industry trends like digitalisation, resource efficiency, individual and zero failure production will drive the photonics industry further.

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

Portable Lab You Plug into Your Phone ca…

Engineers with the University of Cincinnati have created a tiny portable lab that plugs into your phone, connecting it automatically to a doctor's office through a custom app UC developed...

Helping Patients with Binge Eating Disor…

Behavioral therapy assisted by a smartphone app, delivered via telemedicine by a health coach, was an effective treatment for several symptoms of binge eating disorders, according to a study conducted...

SCCE's 8th Annual ECEI - European Compli…

16 - 18 March 2019, Amsterdam, The Netherlands. The European Compliance & Ethics Institute is the place to discuss compliance challenges and strategies with your peers from healthcare and across industry...

InterSystems Releases Novel Coronavirus …

InterSystems is releasing global functionality for its TrakCare® unified healthcare information system to screen and support patients with 2019-nCoV, the novel coronavirus infection that originated in Wuhan in China.

Telehealth Interventions Associated with…

Telehealth interventions are associated with improved obstetric outcomes, according to a review published from physician-researchers at the George Washington University. The article, published in the journal Obstetrics and Gynecology, presents...

CompuGroup Medical to Acquire Certain Ce…

CompuGroup Medical SE (CGM) and Cerner Corporation (NASDAQ: CERN), a global health care technology company, have entered into an agreement regarding the acquisition by CompuGroup Medical of a part of...